Potential of Seaweed to Improve the Quality and Shelf Life of Fish and Fishery Products
Growing global demand for safe fish preservation has increased interest in natural alternatives. Seaweed‐derived bioactive compounds possess antioxidant and antimicrobial properties that enhance fish quality, safety, and shelf life. These sustainable preservatives may reduce spoilage and synthetic preservative use, though further research ...
Ashika Banu Rodela +5 more
wiley +1 more source
Downregulation of Organ-Derived Activin A Attenuates Muscle Atrophy and Intramuscular Fat Infiltration in Cancer Cachexia Mice. [PDF]
Wang C +14 more
europepmc +1 more source
Addressing gaps in cancer cachexia care among healthcare professionals at Uganda Cancer Institute. [PDF]
Darshit D +5 more
europepmc +1 more source
Phloretin Attenuates Cancer Cachexia-Induced Skeletal Muscle Wasting Associated with the Modulation of STAT3 Signaling. [PDF]
Lin K +7 more
europepmc +1 more source
Micheliolide ameliorates colon cancer cachexia by modulating gut microbiota-immune signaling via Phocaeicola vulgatus enrichment. [PDF]
Youn HY +9 more
europepmc +1 more source
Engineered Muscle Tissue Analysis of Irisin Protection Against Glucocorticoid- and Cancer Cachexia-Induced Muscle Wasting and Cardiotoxicity. [PDF]
Son YH +11 more
europepmc +1 more source
Neuroimmune circuit mediates apathy in cancer cachexia. [PDF]
Hai Y, Fan R, Qi F, Zhao M, Wei G.
europepmc +1 more source
Related searches:
Cancer cachexia is a complex syndrome accounting for nearly a third of cancer deaths, characterized by weight loss, anorexia, weakness, anaemia and asthenia. The complications associated with the appearance of the cachectic syndrome affect both the physiological and biochemical balance of the patient, and have effects on the efficiency of the ...
J, Argiles, F, Lopezsoriano
openaire +2 more sources
Cancer cachexia is characterized by metabolic dysregulation, inflammation, and reduced food intake, and it results in loss of skeletal muscle. Although cachexia is pervasive in patients with advanced cancer, comprehensive cac.
Michael S Yule +3 more
+7 more sources

